These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Efficacy of lipid correcting therapy with the use of rosuvastatin]. Ivleva AIa Kardiologiia; 2005; 45(6):71-80. PubMed ID: 16007037 [No Abstract] [Full Text] [Related]
24. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML; JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434 [TBL] [Abstract][Full Text] [Related]
25. [Pronounced lowering of low density cholesterol combined with elevation of high density cholesterol was associated with reduction of coronary atheroma. Results of ASTEROID trial]. Gratsianskiĭ NA Kardiologiia; 2006; 46(5):71-3. PubMed ID: 16858362 [No Abstract] [Full Text] [Related]
26. [Symptomatic coronary heart disease. Impressive plaque reduction with high dose statins]. Einecke D MMW Fortschr Med; 2011 Dec; 153(49-50):18. PubMed ID: 22308585 [No Abstract] [Full Text] [Related]
27. Med could reverse arterial blockages. Health News; 2006 Jul; 12(7):13. PubMed ID: 16858860 [No Abstract] [Full Text] [Related]
28. Statins and prevention of stent-related late adverse events. Uemura S Coron Artery Dis; 2014 Jun; 25(4):277-8. PubMed ID: 24710353 [No Abstract] [Full Text] [Related]
29. Myopathy caused by a combination rosuvastatin and fenofibrate. Dedhia V; Munsi SC J Assoc Physicians India; 2007 Feb; 55():152-3. PubMed ID: 17571748 [No Abstract] [Full Text] [Related]
31. ASTEROID--when spinning a star leads to a collision with reality. Jackson G Int J Clin Pract; 2006 May; 60(5):505. PubMed ID: 16700841 [No Abstract] [Full Text] [Related]
32. The influence of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients. Semenova AE; Sergienko IV; Masenko VP; Ezhov MV; Gabrusenko SA; Kuharchuk VV; Belenkov YN Acta Cardiol; 2009 Jun; 64(3):405-9. PubMed ID: 19593954 [TBL] [Abstract][Full Text] [Related]
33. Cholesterol medication makes a debut in the U.S. Heart Advis; 2003 Oct; 6(10):2. PubMed ID: 15106543 [No Abstract] [Full Text] [Related]
34. NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin. Satoh M; Tabuchi T; Itoh T; Nakamura M Clin Sci (Lond); 2014 Feb; 126(3):233-41. PubMed ID: 23944632 [TBL] [Abstract][Full Text] [Related]
36. HDL cholesterol and residual risk of first cardiovascular events. Saely CH; Vonbank A; Drexel H Lancet; 2010 Nov; 376(9754):1738; author reply 1738-9. PubMed ID: 21093648 [No Abstract] [Full Text] [Related]
37. The cost-effectiveness of rosuvastatin therapy JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin). Hlatky M J Am Coll Cardiol; 2011 Feb; 57(7):792-3. PubMed ID: 21310314 [No Abstract] [Full Text] [Related]
38. [How to prolong life of patients at high cardiovascular risk. Features of rosuvastatin]. Drapkina OM; Korneeva ON Kardiologiia; 2012; 52(8):89-92. PubMed ID: 23098406 [No Abstract] [Full Text] [Related]
39. [Rosuvastatin has no effect on clinical outcomes in patients with heart failure. Results of the GISSI-HF trial]. Preorazhenskiĭ DV Kardiologiia; 2009; 49(4):64-5. PubMed ID: 19463122 [No Abstract] [Full Text] [Related]
40. Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease. Kapur NK Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):161-75. PubMed ID: 17338662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]